Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism
- PMID: 1487241
- DOI: 10.1007/BF00220074
Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism
Abstract
Type I oculocutaneous albinism (OCA) is caused by the reduction in or absence of activity of tyrosinase in melanocytes in skin, hair, and the eyes, the result of mutations of the tyrosinase gene. To date, a total of 22 unique mutations in the coding region of tyrosinase have been described in the literature. In this report we present 5 additional mutations of the tyrosinase gene associated with type I-A OCA in four individuals, including 2 missense, 1 frameshift and 2 nonsense mutations, and review the relevant literature on all published mutations. Analysis of the distribution of all identified missense mutations (n = 17) shows that most cluster in three areas of the gene and involve amino acids conserved between humans and the mouse. Two clusters involve the copper A and copper B binding sites and may disrupt the metal ion-protein interaction necessary for enzyme function. The third cluster in exon I could represent a functional domain important in enzyme function such as the tyrosine or the dihydroxyphenylalanine (DOPA) binding site of the enzyme. Small deletions or insertions resulting in frameshift mutations and nonsense mutations are distributed throughout the coding region and do not appear to cluster.
Similar articles
-
Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.Pigment Cell Res. 1992;Suppl 2:249-53. doi: 10.1111/j.1600-0749.1990.tb00380.x. Pigment Cell Res. 1992. PMID: 1409426
-
Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.Mol Biol Med. 1991 Feb;8(1):19-29. Mol Biol Med. 1991. PMID: 1943686
-
Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism.Pigment Cell Res. 1992 Nov;5(5 Pt 2):274-8. doi: 10.1111/j.1600-0749.1992.tb00549.x. Pigment Cell Res. 1992. PMID: 1292009
-
Mutations of the tyrosinase gene in oculocutaneous albinism.Pigment Cell Res. 1992 Nov;5(5 Pt 2):279-83. doi: 10.1111/j.1600-0749.1992.tb00550.x. Pigment Cell Res. 1992. PMID: 1292010 Review.
-
Tyrosinase gene mutations causing oculocutaneous albinisms.J Invest Dermatol. 1993 Feb;100(2 Suppl):186S-190S. J Invest Dermatol. 1993. PMID: 8433007 Review.
Cited by
-
Genetic Analysis of Oculocutaneous Albinism Type1A (OCA1A) in an Iranian Family.Iran J Public Health. 2010;39(1):100-4. Epub 2010 Mar 31. Iran J Public Health. 2010. PMID: 23112997 Free PMC article.
-
Vision in albinism.Trans Am Ophthalmol Soc. 1996;94:1095-155. Trans Am Ophthalmol Soc. 1996. PMID: 8981720 Free PMC article.
-
Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.Br J Ophthalmol. 2005 Oct;89(10):1383-4. doi: 10.1136/bjo.2005.070243. Br J Ophthalmol. 2005. PMID: 16170149 Free PMC article. No abstract available.
-
Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.Orphanet J Rare Dis. 2012 Jun 26;7:44. doi: 10.1186/1750-1172-7-44. Orphanet J Rare Dis. 2012. PMID: 22734612 Free PMC article.
-
Molecular and clinical characterization of albinism in a large cohort of Italian patients.Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1281-9. doi: 10.1167/iovs.10-6091. Print 2011 Mar. Invest Ophthalmol Vis Sci. 2011. PMID: 20861488 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases